Author

Shuta Tomida

Okayama University HospitalORCID 0000-0003-3786-936XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Hidejiro TorigoeiD· 1 shared Hidetoshi InokawaiD· 1 shared Hiroki SatoiD· 1 shared Hiromasa YamamotoiD· 1 shared Hiroshi DateiD· 1 shared Hiroshige Nakamura· 1 shared Hiroshige YoshiokaiD· 1 shared Hiroyuki SuzukiiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Hidejiro TorigoeORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pharmacology & ToxicologybioRxivPreprintNov 23, 2024

Implication of S-1 biomarkers on aging and prognosis in elderly patients with lung cancer treated by adjuvant S-1 chemotherapy: Accompanying results of the Setouchi Lung Cancer Group Study 1201

Junichi Soh, Hiromasa Yamamoto, Norihito Okumura…·Shinichi Toyooka

The paper examines the impact of S-1 biomarkers on aging and prognosis in elderly lung cancer patients undergoing adjuvant S-1 chemotherapy, finding that high EGFR and low TS expression correlate with better survival outcomes.

DOI 10.1101/2024.11.23.625024

humanbulk RNA-seq

𝕏 PostBluesky